Molecular Testing and Future Prespective Method of nCOV-19

Abstract

A respiratory disease caused by the corona virus is SARS-CoV-2 spread from China to all over the world.
The pathogen causes serious health hazards to humankind from infectious bats. The symptoms range from
mild infection to serious problems and life threatening incidence occur globally. The testing method should
be more rapid for correct diagnosis and clinical laboratories play a pivotal role in COVID-19 testing,
providing presumptive diagnosis at the earliest and nucleic acid based amplification techniques such as RTqPCR
delivering high fidelity reports. The rapid point-of-care testing is crucial in handling such emergency
to enhance large-scale surveillance to aid quarantine of suspicious cases and thereby encasing the contagious
spread. The review focuses on RT-qPCR and future method such as LAMP assay and nano based techniques
are suggested for efficiency and to overcome the false results.